Intravacc

Development & Manufacturing

With decades of experience in vaccine development we help accelerate your vaccine through the value chain, from discovery to phase II.

Intravacc

Analytics

Product characterization is essential, but seldom straightforward. Our experts provide custom analytics to answer your questions.

Intravacc - Bilthoven - The Netherlands - Phone: +31 30 792 03 00 - Email: info@intravacc.nl

Cell Banks MCB / WCB
Virus Seeds MVS / WVS
Pre-clinical + Phase I – III + comm.
Drug Substance Manufacturing
Drug Product Manufacturing
Regulatory Support
Technical Transfer
Stability Tests

Immunogenicity studies
Adjuvant evaluation studies
Dose ranging/finding studies
Toxicology studies

Formulation feasibility
Characterization and assay selection
Formulation optimization
Development stability studies
Device compatibility studies
In-use stability study
Lyophilization

Immunological assays
Biochemical assays
Biophysical assays
Cell-based assays
Analytical chemical assays

Clarification
Chromatography
Tangential Flow Filtration
Dead-end-filtration
Final filtration (sterile 0.2μm)
Lyophilization

Mammalian
Microbial fermentation
Adherent
Suspension
Up to 200L

Viral vaccine design
Bacterial vaccine design
Therapeutic vaccine design
Antigen selection
GMP readiness

Bacterial vaccines
Viral vaccines
Conjugate vaccines
E.coli expressed protein vaccines

Infectious Diseases
Oncology
Immunology
Auto-immune diseases
Neurodegenerative CNS
AntiMicrobial Resistance
Respiratory
Parasitic and fungal

Discovery
Development
Pre-clinical
GMP Manufacturing
Phase I/II
Large-scale manufacturing
Phase III/IV
Registration and distribution